Horizon Pharma Cash from Financing TTM:
164.31M for Dec. 31, 2012Horizon Pharma Historical Cash from Financing TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 164.31M |
| Sept. 30, 2012 | 164.22M |
| June 30, 2012 | 127.68M |
| March 31, 2012 | 134.82M |
| Dec. 31, 2011 | 55.15M |
| Sept. 30, 2011 | 54.17M |
| June 30, 2011 | 22.36M |
| March 31, 2011 | 33.78M |
| Dec. 31, 2010 | 29.76M |
| Sept. 30, 2010 | 36.62M |
| June 30, 2010 | 31.97M |
| March 31, 2010 | 12.24M |
| Dec. 31, 2009 | 11.84M |
About Cash From Financing (TTM)
HZNP Cash from Financing TTM Benchmarks
| Companies | |
|---|---|
| Rigel Pharmaceuticals | 139.09M |
| Sagent Pharmaceuticals | 0.978M |
| Valeant Pharmaceuticals International | 2.331B |
HZNP Cash from Financing TTM Rankings
| Overall |
92nd percentile 605 of 8005 |
| Sector |
92nd percentile 50 of 686 in Healthcare |
| Industry |
89th percentile 7 of 68 in Drug Manufacturers - Specialty & Generic |
HZNP Cash from Financing TTM Range, Past 5 Years
| Minimum | 11.84M | Dec 2009 |
| Maximum | 164.31M | Dec 2012 |
| Average | 67.61M |